ASPH and neoplasm: An in vivo study using an orthotopic rat model of iCCA demonstrated that loading DCs with aspartate-β-hydroxylase (ASPH), a tumor-associated cell surface protein present in several tumors, induced not only suppression of tumor growth and metastasis, but also increased CD3+-lymphocyte infiltration levels into the tumors.